October 27th, 2017

We are very proud to announce that this year’s conference will host the Pfizer Healthcare Challenge Award Ceremony. Finalists of this year’s competition will be honoured for their efforts and present their ideas to challenge sponsors, industry stakeholders, fellow participants and a live audience.  The event will also include a keynote by Peter Albiez, Country Manager Germany at Pfizer, and a panel discussion with the winners and the jury. Pfizer will also host a networking aperitif after the ceremony. The Pfizer Healthcare Challenge Award Ceremony is open to all Frontiers attendees and Pfizer guests. On the first conference day (16^th of November), entrance to the main stage will be 4:30 pm and the ceremony will start at 5 pm. 

The Pfizer Healthcare Challenge 2017 was designed to solve some of the key challenges faced by patients and their clinicians. The winning solution for each category will receive a financial reward of 5.000 Euros, in addition to receiving mentoring from Pfizer experts. After the event, the winning solutions will be further evaluated for the opportunity to co-develop a project or receive a service contract with Pfizer. 

About the Pfizer Healthcare Hub Berlin 

The Pfizer Healthcare Hub Berlin forms an important link between Pfizer Germany and founders and start-ups in the health sector. Founder teams work in close collaboration with Pfizer to develop digital solutions that represent a meaningful complement to therapies and products, for example, in diagnostics or in the monitoring of health data. Pfizer’s support of start-ups is carried out on an individual basis, and includes mentoring sessions from Pfizer’s network of experts, office space, and sales partnerships. The Pfizer Healthcare Hub Berlin was founded in 2014 under the name “Berlin Healthcare Lab”. Since its founding, Pfizer Healthcare Hubs in New York, London, Stockholm, Sydney, Tel Aviv, and Toronto have all followed the example of the Berlin Hub. At the moment, the Berlin Hub is working with the start-ups Cortrium and Viomedo, among others.

< HOME | MORE NEWS  >